Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasin Folkvaljon

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
The Journal of Urology|September 28, 2013
Population based study of predictors of adverse pathology among candidates for active surveillance with Gleason 6 prostate cancerAnnelies Vellekoop, Stacy Loeb, Yasin Folkvaljon, et al.
Acta Oncologica (Stockholm, Sweden)|February 17, 2018
Temporal trends in incidence and outcome of hydatidiform mole: a retrospective cohort studyUrika Joneborg, Yasin Folkvaljon, Nikos Papadogiannakis, et al.
Journal of the National Cancer Institute|November 9, 2017
Meta-Analysis of the Association Between Phosphodiesterase Inhibitors (PDE5Is) and Risk of MelanomaStacy Loeb, Eugenio Ventimiglia, Andrea Salonia, et al.
The Journal of Urology|September 22, 2018
Defining Intermediate Risk Prostate Cancer Suitable for Active SurveillanceStacy Loeb, Yasin Folkvaljon, Ola Bratt, et al.
JAMA Oncology|October 22, 2016
Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in SwedenStacy Loeb, Yasin Folkvaljon, Caitlin Curnyn, et al.
BJU International|July 24, 2014
Upper limit of cancer extent on biopsy defining very low-risk prostate cancerOla Bratt, Yasin Folkvaljon, Stacy Loeb, et al.
European Urology|December 29, 2015
Evaluation of the 2015 Gleason Grade Groups in a Nationwide Population-based CohortStacy Loeb, Yasin Folkvaljon, David Robinson, et al.
European Urology|January 9, 2016
Phosphodiesterase Type 5 Inhibitor Use and Disease Recurrence After Prostate Cancer TreatmentStacy Loeb, Yasin Folkvaljon, David Robinson, et al.
Scandinavian Journal of Urology|October 27, 2018
Work-up and treatment of prostate cancer before and after publication of the first national guidelines on prostate cancer care in SwedenHampus Nugin, Yasin Folkvaljon, Jan-Erik Damber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2017
Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate CancerStacy Loeb, Yasin Folkvaljon, Jan-Erik Damber, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
The Journal of Urology|September 28, 2013
Population based study of predictors of adverse pathology among candidates for active surveillance with Gleason 6 prostate cancerAnnelies Vellekoop, Stacy Loeb, Yasin Folkvaljon, et al.
Acta Oncologica (Stockholm, Sweden)|February 17, 2018
Temporal trends in incidence and outcome of hydatidiform mole: a retrospective cohort studyUrika Joneborg, Yasin Folkvaljon, Nikos Papadogiannakis, et al.
Journal of the National Cancer Institute|November 9, 2017
Meta-Analysis of the Association Between Phosphodiesterase Inhibitors (PDE5Is) and Risk of MelanomaStacy Loeb, Eugenio Ventimiglia, Andrea Salonia, et al.
The Journal of Urology|September 22, 2018
Defining Intermediate Risk Prostate Cancer Suitable for Active SurveillanceStacy Loeb, Yasin Folkvaljon, Ola Bratt, et al.
JAMA Oncology|October 22, 2016
Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in SwedenStacy Loeb, Yasin Folkvaljon, Caitlin Curnyn, et al.
BJU International|July 24, 2014
Upper limit of cancer extent on biopsy defining very low-risk prostate cancerOla Bratt, Yasin Folkvaljon, Stacy Loeb, et al.
European Urology|December 29, 2015
Evaluation of the 2015 Gleason Grade Groups in a Nationwide Population-based CohortStacy Loeb, Yasin Folkvaljon, David Robinson, et al.
European Urology|January 9, 2016
Phosphodiesterase Type 5 Inhibitor Use and Disease Recurrence After Prostate Cancer TreatmentStacy Loeb, Yasin Folkvaljon, David Robinson, et al.
Scandinavian Journal of Urology|October 27, 2018
Work-up and treatment of prostate cancer before and after publication of the first national guidelines on prostate cancer care in SwedenHampus Nugin, Yasin Folkvaljon, Jan-Erik Damber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2017
Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate CancerStacy Loeb, Yasin Folkvaljon, Jan-Erik Damber, et al.
Pageof 3